| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 10/03/2007 | EP1412383B9 Peptide conjugates, their derivatives with metal complexes and use thereof for magnetic resonance imaging (mri) |
| 10/03/2007 | EP1262490B1 GPib-LIPID BOND CONSTRUCT AND USE THEREOF |
| 10/03/2007 | CN101045736A Double phospho acid compound of 99mT.C. mark and preparation method |
| 10/03/2007 | CN100340299C Method for preparing radioactive nuclide magnetic microsphere used in vivo |
| 10/03/2007 | CN100340291C F1t4(VEGFR-3) as target for tumor imaging and anti-tumor therapy |
| 10/02/2007 | US7276254 Emulsion/aggregation polymeric microspheres for biomedical applications and methods of making same |
| 09/27/2007 | WO2007109475A2 Chelation of metals to thiol groups using in situ reduction of disulfide-containing compounds by phosphines |
| 09/27/2007 | WO2007038496A3 Synthesis of fatty alcohol esters of hydroxy carboxylic acids, the use of the same as percutaneous permeation enhancers |
| 09/27/2007 | WO2006043083A8 Liposomes enclosing a radionuclide and a cytotoxic agent for combination therapy |
| 09/27/2007 | US20070225779 Treatment of vitiligo by micropore delivery of cells |
| 09/27/2007 | US20070225218 Extracellular Messengers |
| 09/27/2007 | US20070224127 Cardiovascular disorders such as myocardial infarction, post-myocardial infarction remodeling, and congestive heart failure |
| 09/27/2007 | US20070224119 Toxins and radionuclides coupled to IGF-1 receptor ligands for treatment of cancer |
| 09/27/2007 | US20070224117 bis-carboxyethylgermanium sesquioxide; contrast agent for imaging organs, particularly, spleen; increases interferon and natural killer cell activity; induces peritoneal macrophage activity; immuno-enhancement, oxygen enrichment, free radical scavenging, analgesia and heavy metal detoxification |
| 09/27/2007 | US20070224116 Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents |
| 09/27/2007 | US20070224115 Polymeric chelators for radionuclide delivery systems |
| 09/27/2007 | CA2679610A1 Healing powder and method of use thereof |
| 09/26/2007 | EP1836204A2 Radioactive metal complexes based on bispidine and derivatives thereof |
| 09/26/2007 | EP1836171A1 6-(2,3,4,5-tetrahydro-1h-benzo[d]azepin-7-yloxy)-nicotamide derivatives as radiolabelled ligands |
| 09/26/2007 | EP1644049B1 Method and device for radiotherapy |
| 09/26/2007 | EP1047708B1 Peptide chelators that predominately form a single stereoisomeric species upon coordination to a metal center |
| 09/26/2007 | CN101041674A Tumor imaging compounds |
| 09/26/2007 | CN101041081A Rhenium anti-liver cancer single-anti-magnetic nanometer body and the method for preparing the same |
| 09/25/2007 | US7273951 Polyhydroxy phenols and their use in binding p-selectin |
| 09/25/2007 | US7273608 Humanized anti-CEA T84.66 antibody and uses thereof |
| 09/25/2007 | US7273601 Preparation of radiolabelled haloaromatics via polymer-bound intermediates |
| 09/25/2007 | US7273600 unit dose comprises a sufficient amount for in vivo diagnostic imaging of a 2'-deoxy-2'-[18F]- or a 3'-deoxy-3'-[18F]-labeled purine analog for being detected in vivo |
| 09/25/2007 | CA2279349C Ascorbate-stabilized radiopharmaceutical method and composition |
| 09/25/2007 | CA2204160C Treatment of urogenital cancer with boron neutron capture therapy |
| 09/20/2007 | WO2007106544A2 Chelating conjugates having a substituted aromatic moiety and derivatives thereof |
| 09/20/2007 | WO2007104135A1 Bifunctional polyazamacrocyclic chelating agents |
| 09/20/2007 | WO2007042781A3 Automated method for preparing technetium complexes |
| 09/20/2007 | WO2006107794A3 Poly(peptide) as a chelator: methods of manufacture and uses |
| 09/20/2007 | US20070218056 Methods for identification, diagnosis, and treatment of breast cancer |
| 09/20/2007 | US20070217998 Locoregional internal radionuclide ablation of abnormal tissues |
| 09/20/2007 | US20070217997 comprising heavy chain and light chain immunoglobulin variable domain sequences; (complementary determining regions) CDR/antibodies, used to treat or prevent metastasis, hyperproliferation, inflammation and disorders characterized by excessive extracellular matrix degradation; enzyme inhibitors |
| 09/20/2007 | US20070217996 Activatable Particles, Preparations and Uses |
| 09/20/2007 | CA2645666A1 Chelating conjugates having a substituted aromatic moiety and derivatives thereof |
| 09/19/2007 | EP1834267A2 Pf4 pharmacophores and their uses |
| 09/19/2007 | EP1833514A2 Phospholipid ether analogs for detecting and treating cancer |
| 09/19/2007 | EP1474396B1 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof |
| 09/19/2007 | CN101039702A Heat shock protein as a targeting agent for endothelium-specific in vivo transduction |
| 09/18/2007 | US7271171 Adenosine A3 receptor modulators |
| 09/18/2007 | US7270800 Imaging amyloid deposits in living patients, with an amyloid binding agents having radiolabeled iodine; radiotherapy |
| 09/18/2007 | US7270799 compounds such as 2-methyl-2(3-fluoropropyl)-malonic Acid that selectively bind to cells undergoing perturbations and alterations of their normal plasma membrane organization, i.e., cells undergoing cell death, apoptotic cells or activated platelets |
| 09/18/2007 | CA2216919C Nanospheres comprising a biocompatible polysaccharide |
| 09/13/2007 | WO2007101332A1 Cancerous disease modifying antibodies for diagnostic and therapeutic use in breast and ovarian cancer |
| 09/13/2007 | WO2007101331A1 Cancerous disease modifying antibodies for diagnostic and therapeutic use in breast and prostate cancer |
| 09/13/2007 | US20070213750 Composite Staple for Completing an Anastomosis |
| 09/13/2007 | US20070212368 Proteins |
| 09/13/2007 | US20070212350 Rs7 antibodies |
| 09/13/2007 | US20070212303 Sterically stabilized liposomes with hydrophilic polymers on surface; computed tomography |
| 09/13/2007 | US20070212299 A gene (designated 161P2F10B) and its encoded protein which exhibits tissue specific expression in normal adult tissue and is aberrantly expressed in the cancers; medical diagnostis;, prognosis, prophylactis and/or gene therapy; tissue-target therapy; used to elicit a humoral or cellular immune response |
| 09/13/2007 | US20070212298 Use of the combination comprising temozolomide and tnf-alpha for treating glioblastoma |
| 09/13/2007 | US20070212297 Amino methyl imidazoles and related compounds as C5a receptor modulators |
| 09/13/2007 | CA2644782A1 Cancerous disease modifying antibodies for diagnostic and therapeutic use in breast and ovarian cancer |
| 09/13/2007 | CA2644774A1 Cancerous disease modifying antibodies for diagnostic and therapeutic use in breast and prostate cancer |
| 09/12/2007 | EP1830890A2 Radiolabelled conjugates of rgd-containing peptides and methods for their preparation via click-chemistry |
| 09/12/2007 | EP1197227B1 Method of the administration of drugs having binding affinity with plasma protein and preparation to be used in the method |
| 09/12/2007 | CN101035568A Combination therapy using transferrin fusion proteins comprising GLP-1 |
| 09/12/2007 | CN101035567A Novel technetium and rhenium complexes, ligands used in their preparation and their use as radiopharmaceuticals |
| 09/12/2007 | CN101035566A Immunotherapy of autoimmune disorders |
| 09/12/2007 | CN101035565A Compounds, kits and methods for use in medical imaging |
| 09/11/2007 | US7268220 Chelation compounds, radionuclide metal chelate compounds (i.e., complexes) and radiolabeled targeting moieties (i.e., conjugates) formed therefrom, and methods of making and using these compounds, complexes and conjugates for diagnostic and therapeutic purposes |
| 09/11/2007 | CA2417392C Radiopharmaceutical for diagnostic imaging containing a technetium-99m nitride heterocomplex |
| 09/07/2007 | WO2007099536A2 Radioactive metal-bound beads |
| 09/07/2007 | WO2007098575A1 Cytotoxicity mediation of cells evidencing surface expression of cd44 |
| 09/07/2007 | WO2007042791A3 Automated radiolabelling method |
| 09/07/2007 | CA2643708A1 Cytotoxicity mediation of cells evidencing surface expression of cd44 |
| 09/07/2007 | CA2643145A1 Bifunctional resorcinol, thioresorcinol, and dithioresorcinol derivative metal chelating conjugates |
| 09/06/2007 | US20070207146 Therapeutic using a bispecific antibody |
| 09/06/2007 | US20070207143 Anti-cd26 monoclonal antibodies as therapy for diseases associated with cells expressing cd26 |
| 09/06/2007 | US20070207086 Compounds that bind to P185 and methods of using the same |
| 09/05/2007 | EP1828247A2 Binding molecules capable of neutralizing west nile virus and uses thereof |
| 09/05/2007 | EP1828238A1 Method for isolating neural cells using tenascin-r compounds |
| 09/05/2007 | EP1827509A2 Method of imaging cell death in vivo |
| 09/05/2007 | EP1827506A2 Targeting contrast agents or targeting therapeutic agents for molecular imaging and therapy |
| 09/05/2007 | EP1827239A2 Positron emission tomography imaging method |
| 09/05/2007 | EP1283719B1 Apoptotic agents |
| 09/05/2007 | CN101031319A Radiosensitizer conjugate to improve the efficacy of radiolabeled drugs |
| 09/05/2007 | CN101029058A 99mTcN nuclear marked piperazine famicid salt complex, its preparation and use |
| 09/05/2007 | CN101028525A Use of tumor caryon single-antibody in physical therapeutic tumor as synergist |
| 09/05/2007 | CN101028259A Water soluble paclitaxel product |
| 09/04/2007 | US7265201 Human chemotactic cytokine |
| 09/04/2007 | US7265199 Anticoagulant; for devices for preventing excessive cellular proliferation; wrappings for stents |
| 09/04/2007 | US7265086 Useful as antibacterial agents |
| 09/04/2007 | US7264805 Proteins with a high immunoreactivity and a method for the production thereof |
| 09/04/2007 | US7264792 Treatment of a solid support-bound precursor of formula:SOLID SUPPORT-LINKER-SO2 O-TRACER with 18F- to produce the labelled tracer, removal of excess 18F-, for example by ion-exchange chromatography; and/or removal of any protecting groups; and/orremoval of organic solvent |
| 09/04/2007 | US7264791 Mixing a pertechnetate, antimony trisulfide nanocolloid and a reducing agent to provide a mixture, and stirring the mixture to obtain said complex, wherein the reducing agent is borohydride exchange resin |
| 08/30/2007 | WO2007096194A1 Radio-labeled isoxazole derivatives useful for the labeling and diagnostic of hsp90 functionality |
| 08/30/2007 | WO2007095749A1 Cytotoxicity mediation of cells evidencing surface expression of trop-2 |
| 08/30/2007 | WO2007095748A1 Cancerous disease modifying antibody 141205-05 |
| 08/30/2007 | WO2007095746A1 Cancerous disease modifying antibodies |
| 08/30/2007 | WO2007095745A1 Cancerous disease modifying antibody 141205-02 |
| 08/30/2007 | WO2007030571A3 Identification of targets and development of reagents for testing and molecular imaging of human disease |
| 08/30/2007 | US20070202044 Antibody therapy |
| 08/30/2007 | US20070202043 Cell surface glycoprotein specific immunoglobulin for use in prevention and treatment of cell proliferative disorders; antitumor agents |
| 08/30/2007 | US20070202042 Isolated monoclonal antibody produced by hybridoma deposit IDAC accession number 141205-02; customization of therapy for each individual; kits |
| 08/30/2007 | US20070202041 Cancerous disease modifying antibodies |
| 08/30/2007 | US20070202040 Supplying radionuclide to blood clot; ultrasonic imaging; diagnosis, therapy |